Industries > Pharma > Global Norovirus Vaccines in Pipeline Forecast 2020-2030

Global Norovirus Vaccines in Pipeline Forecast 2020-2030

Takeda, Vaxart, Cocrystal Pharma, PanTheryx, Calici Therapeutics

PUBLISHED: 19 December 2019
PAGES: 98
PRODUCT CODE: PHA0643
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1
SKU: PHA0643 Categories: , Tags: , , , , ,

The global norovirus vaccines market is estimated to grow at a CAGR of 7.6% during the forecast period. In 2022, North America is expected to hold a market share of 61% of the global norovirus vaccines market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

The report provides clear detailed insight into the global norovirus vaccines in pipeline forecast. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Norovirus Vaccines in Pipeline forecast from 2020-2030

• Global Norovirus Vaccines in Pipeline forecast from 2020-2030 by Regional and National Market:
• North America: US, Canada
• EU5: Germany, France, UK, Italy, Spain
• APAC: Japan, China, India, Australia, ASEAN, Rest of APAC
• Central and South America: Brazil, Argentina, Rest of Central and South America
• Middle East and Africa: GCC, South Africa, North Africa, Rest of MEA

Global Norovirus Vaccines in Pipeline Forecast 2020-2030

• Profiles of the selected leading companies:
• Calici Therapeutics
• Cocrystal Pharma
• PanTheryx
• Takeda
• Vaxart

• List and discussion of candidate vaccines

• Key Questions Answered by this Report:
• What is the current size of the overall global norovirus vaccines market? How much will this market be worth from 2020 to 2030?
• What are the main drivers and restraints that will shape the overall norovirus vaccine market over the next ten years?
• What factors will affect that industry and market over the next ten years?
• What are the largest national markets for the world vaccines? What is their current status and how will they develop over the next ten years? What are their revenue potentials to 2030?
• How will market shares of the leading national markets change by 2030, and which geographical region will lead the market in 2030?
• Who are the leading companies and what are their activities, results, developments and prospects?
• What are some of the most prominent norovirus vaccines currently in development?
• What are the main trends that will affect the world norovirus vaccines market between 2020 and 2030?
• What are the main strengths, weaknesses, opportunities and threats for the market?
• What are the demographic influences that will shape that industry over the next ten years?
• How will the global norovirus vaccines market evolve over the forecasted period, 2020 to 2030?

Buy our report today Global Norovirus Vaccines in Pipeline Forecast 2020-2030: Takeda, Vaxart, Cocrystal Pharma, PanTheryx, Calici Therapeutics.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Global Norovirus Vaccines in Pipeline Forecast 2020-2030


Download sample pages

Complete the form below to download your free sample pages for Global Norovirus Vaccines in Pipeline Forecast 2020-2030


Latest Pharma news

Visiongain Publishes Respiratory Inhalers Market Report 2021-2031

Product approval is a major milestone facing all key competitors in the respiratory inhalers market. Several strategies were implemented by key market players between 2015 and Jan 2021.

26 February 2021

READ

Visiongain Publishes Bile Duct Cancer Drugs Market Report to 2031

The global bile duct cancer drug market has been growing considerably owing to the rising incidence and prevalence rate of bile duct cancer patients worldwide, technological advancement in drug development, and healthcare spending.

22 February 2021

READ

Visiongain Publishes Big Data Analytics in Healthcare Market Report to 2031

The global Big Data Analytics in Healthcare market has been growing considerably owing to the rising technological advancement, growing investment, and cohesive government policies.

22 February 2021

READ

Visiongain Publishes Behavioural Health Market Report to 2031

The global behavioural Health market has been growing considerably owing to the rising pressure/stress at work, growing incidence and prevalence rate of depression and PTSD (Post Traumatic Stress Disorder) around the globe.

22 February 2021

READ

Categories